about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesOral epithelial cells and their interactions with HIV-1.HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Proteomic signatures of human oral epithelial cells in HIV-infected subjectsThe novel Candida albicans transporter Dur31 Is a multi-stage pathogenicity factor.Evidence of an increased pathogenic footprint in the lingual microbiome of untreated HIV infected patients.Secretory products of Escherichia coli biofilm modulate Candida biofilm formation and hyphal development.Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions.Candida concentrations determined following concentrated oral rinse culture reflect clinical oral signsSalivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study.Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapyOral innate immunity in HIV infection in HAART eraNormal adaptation of Candida albicans to the murine gastrointestinal tract requires Efg1p-dependent regulation of metabolic and host defense genes.Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection.Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.Secretory immunity with special reference to the oral cavity.Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation.Cytological and cytomorphometric evaluation of the oral mucosa in HIV-infected patients undergoing antiretroviral therapy.Clinical, pathological, immunohistochemical and molecular characterization of feline chronic gingivostomatitis.Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.Oral Cytology for HIV: A New Diagnostic Tool?
P2860
Q22241377-119C2D12-E68C-45BA-9891-437CEC2EFC3CQ30384510-381F11BA-DA14-4E55-BEA1-AB7F5EB1C81CQ33646773-F4B4E77C-D01B-47BC-B1D7-3DB670A83C6CQ33654841-87E5BD0A-D2F4-4590-B78E-3DE31D56EE59Q34082869-5ECBD095-182D-4EFB-84B9-194F91F8C301Q34205894-B85A8F9E-EAEE-4227-862B-D5F432FD8B80Q34353915-2F295928-54CC-4456-9B82-2C06CBE0F944Q34772759-130181E3-A1EC-4500-ACA9-67AA3D0AB972Q35624490-0ED3BC77-C813-48CB-93C1-AE6443B91B16Q35849138-644EF17A-07DE-4706-99F3-AB2D79F37989Q35877124-8A9AA261-BD7C-4F90-A009-FED7A449A83AQ36243619-60362B1F-5CB0-4482-9ED0-B89000321770Q36352384-BA4645E5-587A-44C6-A0CE-9BB8146A002CQ36505103-16B14198-5828-4FEC-8145-7C203BFED7F9Q36516875-E6D5BAE8-C574-4F39-9F70-293EEADBB129Q36674118-0430A44E-38F6-4BF5-818B-CA865C2ED207Q36678122-DF27CF15-8B30-486A-85C2-6624E4417A40Q37379784-1D2C87F7-120B-4B40-BEA3-A7440862F5C7Q37384307-D291BDE2-5AF1-4869-8959-7B728EFE8D08Q37683137-2FDAF07E-22F5-40A3-A1D0-1669F275A6D7Q40212864-3722BFCD-2ACB-4347-A217-CDDBB3C28BA9Q40921180-9C0CB0C2-6C9A-43AA-BEBE-452041771E62Q41125894-4C9F8A14-B6E0-4772-920D-9E8709ED13F0Q46701553-85BF5874-45E0-4003-BA70-AF55AD455988Q56767785-F3067FEB-57B4-4663-9E54-309673D5382E
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The effects of HIV infection on oral mucosal immunity.
@ast
The effects of HIV infection on oral mucosal immunity.
@en
type
label
The effects of HIV infection on oral mucosal immunity.
@ast
The effects of HIV infection on oral mucosal immunity.
@en
prefLabel
The effects of HIV infection on oral mucosal immunity.
@ast
The effects of HIV infection on oral mucosal immunity.
@en
P2860
P1476
The effects of HIV infection on oral mucosal immunity
@en
P2093
J R Naglik
S J Challacombe
P2860
P356
10.1177/154407370601900107
P577
2006-04-01T00:00:00Z